Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 196


Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.

James SK, Armstrong P, Barnathan E, Califf R, Lindahl B, Siegbahn A, Simoons ML, Topol EJ, Venge P, Wallentin L; GUSTO-IV-ACS Investigators.

J Am Coll Cardiol. 2003 Mar 19;41(6):916-24.


Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.

Westerhout CM, Fu Y, Lauer MS, James S, Armstrong PW, Al-Hattab E, Califf RM, Simoons ML, Wallentin L, Boersma E; GUSTO-IV ACS Trial Investigators.

J Am Coll Cardiol. 2006 Sep 5;48(5):939-47.


[C-reactive protein as an independent marker of prognosis in acute coronary syndrome: comparison with troponin T].

Möckel M, Heller G Jr, Müller C, Klefisch FR, Riehle M, Searle J, Frei U, Störk T.

Z Kardiol. 2000 Aug;89(8):658-66. German.


Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.

James SK, Lindbäck J, Tilly J, Siegbahn A, Venge P, Armstrong P, Califf R, Simoons ML, Wallentin L, Lindahl B.

J Am Coll Cardiol. 2006 Sep 19;48(6):1146-54. Epub 2006 Aug 28.


Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.

Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.

Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):144-50. doi: 10.1016/j.carrev.2009.01.005.


Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.

Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Simoons ML, Zeiher AM; CAPTURE Study Investigators.

J Am Coll Cardiol. 2005 Jan 18;45(2):229-37.


Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).

James SK, Lindahl B, Timmer JR, Ottervanger JP, Siegbahn A, Stridsberg M, Armstrong P, Califf R, Wallentin L, Simoons ML.

Am J Cardiol. 2006 Jan 15;97(2):167-72. Epub 2005 Nov 21.


A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.

Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY.

J Intern Med. 2007 Dec;262(6):651-8. Epub 2007 Nov 7.


Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.

Palazzuoli A, Deckers J, Calabrò A, Campagna MS, Nuti R, Pastorelli M, Pasqui AL, Bruni F, Auteri A, Puccetti L.

Am J Cardiol. 2006 Nov 15;98(10):1322-8. Epub 2006 Sep 28.


Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial.

James S, Armstrong P, Califf R, Simoons ML, Venge P, Wallentin L, Lindahl B.

Am J Med. 2003 Aug 15;115(3):178-84.


Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E.

Circulation. 2002 Apr 16;105(15):1760-3.


C-reactive protein increase in unstable coronary disease cause or effect?

De Servi S, Mariani M, Mariani G, Mazzone A.

J Am Coll Cardiol. 2005 Oct 18;46(8):1496-502. Epub 2005 Sep 28. Review.


Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients.

Oldgren J, James SK, Siegbahn A, Wallentin L.

Eur Heart J. 2007 Mar;28(6):699-704. Epub 2007 Feb 21.


Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.

Ohman EM, Armstrong PW, White HD, Granger CB, Wilcox RG, Weaver WD, Gibler WB, Stebbins AL, Cianciolo C, Califf RM, Topol EJ.

Am J Cardiol. 1999 Dec 1;84(11):1281-6.


Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.

Cavusoglu E, Ruwende C, Eng C, Chopra V, Yanamadala S, Clark LT, Pinsky DJ, Marmur JD.

Am J Cardiol. 2007 May 15;99(10):1364-8. Epub 2007 Apr 5.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk